Home AlgoNomics

AlgoNomics

acquired
-
A company that provides structural bioinformatics services to develop rationally designed therapies in the field of immunotherapy.

Basic Information

AlgoNomics is a biotechnology company located in Belgium that provides structural bioinformatics services to develop rationally designed therapies in the broad field of immunotherapy. AlgoNomics has a rich proprietary platform for structure-based protein and peptide design. This technology platform includes innovative tools for unraveling protein-protein and protein-peptide interactions. AlgoNomics' leading product is the Epibase® platform, used for T-cell epitope identification in different populations, aiding in the discovery of vaccines and therapeutic proteins.
--
Antwerp,Flemishregion,Belgium
more than 500 people
January 01, 1999
info@algonomics.com